Cingulate logo

Cingulate

CING • NASDAQ • Stock Fundamentals

Cingulate is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Shane J. Schaffer, with a market cap of $59.3M.

Market Cap$59.3M
Employees13.0
CEOShane J. Schaffer
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 14, 2026 · 13 days agoQ1 2026
View report
Next EarningsAug 18, 2026 · in 3 monthsBefore Market Open · Q2 2026
Income StatementBalance SheetCash FlowSegments

Financials

Based on Q1 2026 filing

View all metrics
CIN

Cingulate FAQ

Common questions about Cingulate

Cingulate (CING) has a market capitalization of $59.3M and trades on NASDAQ.

Cingulate has approximately 13 employees.